• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Co-trimoxazole versus dapsone-pyrimethamine for prevention of Pneumocystis carinii pneumonia.

作者信息

Coker R J, Nieman R, McBride M, Mitchell D M, Harris J R, Weber J N

出版信息

Lancet. 1992 Oct 31;340(8827):1099. doi: 10.1016/0140-6736(92)93120-c.

DOI:10.1016/0140-6736(92)93120-c
PMID:1357487
Abstract
摘要

相似文献

1
Co-trimoxazole versus dapsone-pyrimethamine for prevention of Pneumocystis carinii pneumonia.复方新诺明与氨苯砜-乙胺嘧啶预防卡氏肺孢子虫肺炎的比较
Lancet. 1992 Oct 31;340(8827):1099. doi: 10.1016/0140-6736(92)93120-c.
2
Low-dose co-trimoxazole, aerosolised pentamidine, or dapsone plus pyrimethamine for prevention of Pneumocystis carinii pneumonia.
Lancet. 1991 May 11;337(8750):1162-3. doi: 10.1016/0140-6736(91)92829-q.
3
Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.与氨苯砜-乙胺嘧啶相比，间断使用甲氧苄啶-磺胺甲恶唑对感染HIV患者同时进行肺孢子菌肺炎和弓形虫病的原发性预防。
Ann Intern Med. 1995 May 15;122(10):755-61. doi: 10.7326/0003-4819-122-10-199505150-00004.
4
Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.对人类免疫缺陷病毒（HIV）感染患者预防卡氏肺孢子虫肺炎和弓形虫性脑炎治疗方法的荟萃分析。
J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jun 1;15(2):104-14. doi: 10.1097/00042560-199706010-00002.
5
Four different regimens for prevention of Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
AIDS. 1994 Feb;8(2):272-4. doi: 10.1097/00002030-199402000-00021.
6
From the Centers for Disease Control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus.来自疾病控制中心。针对感染人类免疫缺陷病毒儿童的卡氏肺孢子虫肺炎预防指南。
JAMA. 1991 Apr 3;265(13):1637-40, 1643-4.
7
A controlled trial of dapsone versus pyrimethamine-sulfadoxine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmosis in patients with AIDS.
Biomed Pharmacother. 1997;51(10):439-45. doi: 10.1016/s0753-3322(97)82322-0.
8
Prevention of infection due to Pneumocystis carinii.预防卡氏肺孢子虫感染。
Antimicrob Agents Chemother. 1998 May;42(5):995-1004. doi: 10.1128/AAC.42.5.995.
9
Prophylaxis of pneumocystis pneumonia and toxoplasmosis.
Ann Intern Med. 1996 Jun 15;124(12):1096. doi: 10.7326/0003-4819-124-12-199606150-00017.
10
Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus.针对感染人类免疫缺陷病毒儿童的卡氏肺孢子虫肺炎预防指南。
MMWR Recomm Rep. 1991 Mar 15;40(RR-2):1-13.

引用本文的文献

1
Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.非HIV免疫功能低下患者肺孢子菌肺炎（PCP）的预防
Cochrane Database Syst Rev. 2014 Oct 1;2014(10):CD005590. doi: 10.1002/14651858.CD005590.pub3.
2
Patients unaware of their HIV status present to inner city accident and emergency department with respiratory complications.未意识到自身感染艾滋病毒的患者因呼吸并发症前往市中心的急诊部门就诊。
J Accid Emerg Med. 1997 Sep;14(5):304-6. doi: 10.1136/emj.14.5.304.
3
Population pharmacokinetics of dapsone administered biweekly to human immunodeficiency virus-infected patients.
每两周给人类免疫缺陷病毒感染患者服用氨苯砜的群体药代动力学。
Antimicrob Agents Chemother. 1996 Dec;40(12):2743-8. doi: 10.1128/AAC.40.12.2743.
4
Pharmacokinetics and safety of weekly dapsone and dapsone plus pyrimethamine for prevention of pneumocystis pneumonia.每周服用氨苯砜以及氨苯砜加乙胺嘧啶预防肺孢子菌肺炎的药代动力学及安全性
Antimicrob Agents Chemother. 1994 Jul;38(7):1580-7. doi: 10.1128/AAC.38.7.1580.
5
AIDS and the lung: update 1995. 1. Pneumocystis carinii pneumonia.艾滋病与肺部：1995年最新进展。1. 卡氏肺孢子虫肺炎
Thorax. 1995 Feb;50(2):191-200. doi: 10.1136/thx.50.2.191.
6
Pharmacokinetics of dapsone in human immunodeficiency virus-infected children.氨苯砜在人类免疫缺陷病毒感染儿童中的药代动力学。
Antimicrob Agents Chemother. 1995 May;39(5):1101-6. doi: 10.1128/AAC.39.5.1101.
7
HIV positive patients first presenting with an AIDS defining illness: characteristics and survival.首次出现艾滋病定义疾病的HIV阳性患者：特征与生存情况。
BMJ. 1995 Jul 15;311(6998):156-8. doi: 10.1136/bmj.311.6998.156.